Freshly Printed - allow 7 days lead
Couldn't load pickup availability
Pharmacological Treatment of Alzheimer's Disease
Molecular and Neurobiological Foundations
Jorge D. Brioni (Edited by), JD Brioni (Author), Michael W. Decker (Edited by)
9780471167587, Wiley
Hardback, published 21 March 1997
549 pages
24.2 x 16.5 x 3.3 cm, 0.992 kg
Geboten wird ein vollständiger, ausgewogener Überblick über die neuropharmakologischen Grundlagen von Therapeutika für die Alzheimer-Krankheit. Neueste Untersuchungen molekularer Strukturen und aktuelle klinische Daten werden mit der Verhaltens- und Erkenntnisforschung verknüpft und interpretiert.
I -
The Neurology of Cognition: Structure and Management of Multiple Memory Systems in Alzheimer's Disease
Interaction of Neuromodulatory Systems Regulating Memory Storage
Monoamine and Acetylcholine Influences on Higher Cognitive Functions in Nonhuman Primates with Relevance to the Treatment of Alzheimer's Disease
Cortical Acetylcholine and Attention: Neuropharmacological and Cognitive Principles Directing Treatment Strategies for Cognitive Disorders
Neuropsychological Features of Alzheimer's Disease
II -
Neuropathological Features of Alzheimer's Disease
Normal Brain Ageing and Alzheimer's Disease Pathology
Recent Developments in the Genetics of Alzheimer's Disease
Neurofibrillary Tangles in Alzheimer's Disease: Clinical and Pathological Implications
Amyloid Cytoxicity and Alzheimer's Disease: Roles of Membrane Oxidation and Perturbed Ion Homeostasis
The Role of Apolipoprotein E in Neurobiology and the Pathogenesis of Alzheimer's Disease
Animal Models Relevant to Alzheimer's Disease
III -
Alzheimer's Drug Discovery and Development: Alzheimer's Disease: An International Public Health Problem- Clinical Goals, Strategies and Outcomes
Use of CSF-based Markers in the Diagnosis of Alzheimer's Disease
Considerations for Clinical Trials in Alzheimer's Disease
Cholinesterase Inhibition in the Treatment of Alzheimer's Disease: Further Evaluation of the Clinical Effects of Tucrine
Development of Muscarinic Agonists for the Symptomatic Treatment of Alzheimer's Disease
Neuronal Nicotinic Receptors: Potential Treatment for Alzheimer's Disease with Novel Cholinergic Channel Activators
Neurotrophic Factors: Potential for Therapeutic Intervention in Alzheimer's Disease
A Fundamental Role for Estrogens in Cognition and Neuroprotection
Alzheimer's Disease: Prospects for Treatment in the Next Decade.
Subject Areas: Biology, life sciences [PS]
